Physician profile
John S Macgregor
NPI 1831131846
$868.65
in general payments reported to CMS, 2019-2025
12 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.33 · 2020: $34.25 · 2021: $31.00 · 2022: $346 · 2023: $61.94 · 2024: $147 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $183.71 | 2022 | |
| Impulse Dynamics (USA) INC. | $162.74 | 2022 | |
| Abbott Laboratories | $129.07 | 2024-2025 | Aveir, Assurity, Agilis Hispro |
| Boston Scientific Corporation | $103.59 | 2021-2025 | Avvigo Guidance System, General - Balloon Catheters |
| Medtronic Vascular, INC. | $80.61 | 2019-2020 | |
| Terumo Medical Corporation | $61.63 | 2024 | Azur Cx Detachable, Heartrail, Glidewire |
| Teleflex LLC | $37.35 | 2023 | Guideliner |
| Shockwave Medical, INC | $30.36 | 2025 | |
| Pfizer INC. | $25.03 | 2025 | |
| Philips North America LLC | $24.59 | 2023 | |
| Astellas Pharma US INC | $24.23 | 2019 | |
| Cardiovascular Systems INC. | $5.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Macgregor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.